Where higher quality leads to improved lives

AIS Healthcare does more to advance targeted drug delivery (TDD).

From compliance procedures that far exceed industry standards to finding new ways to put quality at the forefront throughout the compounding process, we are committed to exceeding requirements and expectations in every patient prescription we deliver.

At the heart of this commitment are our two state-of-the-art pharmacies, our headquarters in Dallas, Texas, and a location in Ridgeland, Mississippi. Throughout these facilities, we take extra steps and make extra investments to go beyond industry requirements and produce medications of the highest quality and sterility.


patient-specific prescriptions provided per year


pump patients served per year


pharmacists dedicated to the preparation of TDD medications


third-party testing of all stock solutions*

*Third-party testing for pH, sterility, potency, endotoxins and particulate matter


day BUD at room temperature (average 34 days) for all formulary medications, eliminating the stress of missed appointments

All patient-specific dispenses within maximum concentrations (based on AIS Healthcare in-house data for 120,000 aseptically processed and terminally sterilized patient-specific prescriptions in 2019)


sterility assurance level for unprecedented quality and patient safety

Recognized and accredited

We are regularly inspected by national and state boards of pharmacy as well as the U.S. Drug Enforcement Administration and the U.S. Food and Drug Administration (with zero Form 483 observations on the last inspection). We are PCAB-accredited for sterile compounding, and dually accredited by URAC and the Accreditation Commission for Health Care (ACHC).

URAC seal
ARHC seal


Beyond industry standards

All 503A specialty compounding pharmacies like ours must meet United States Pharmacopeia (USP) guidelines along with all state and local regulations. In many ways, we far exceed these requirements, doing more to put patient safety first.

Here are some of the many ways we’re exceeding industry standards:

AIS Healthcare quality standard USP <797> guidelines
All stock solutions are prepared by a licensed pharmacist and tested by an outside, independent lab for sterility, potency, particulate matter, pH and endotoxins before use in compounding Not required
Compounding done only by licensed pharmacists Compounder not required to be licensed pharmacist
Enhanced contamination-control procedures, including full-body sterile garb for cleanroom personnel Only sterile gloves required for cleanroom personnel
Multiple 0.22-micron sterilizing-grade filtration steps, including filter integrity testing, to ensure medication sterility Only one 0.22-micron sterilizing-grade filtration step required
Four independent cleanroom certifications per year Only two required per year
Non-viable particle count done 12 times per year; combined viable air and surface sampling done no fewer than 50 times per year Non-viable particle count and viable air sampling required twice per year; surface sampling required periodically

With a proven, proprietary process that combines aseptic processing with terminal sterilization—a pharmaceutical industry standard that only AIS Healthcare uses—we are able to achieve unprecedented sterility assurance and extended beyond-use-date (BUD).